Skip to main content
. 2014 Sep 9;20(2):167–174. doi: 10.1111/anec.12197

Table 3.

PW Duration and Derived Indices in AF versus Control Patients with Hazard Ratios and 95% Confidence Intervals

Univariate Analysis Multivariate Analysis
AF Group Control Hazard Hazard
(n = 44) Group (n = 44) P Value Ratio (95% CI) P Value Ratio (95% CI) P Value
P‐wave duration (ms)
I 104 ± 19 93 ± 17 0.01 1.03 (1.00–1.06) 0.01 1.03 (1.00–1.06) 0.02
II 113 ± 23 109 ± 17 0.35 1.01 (0.98–1.03) 0.35
III 101 ± 18 95 ± 17 0.17 1.02 (0.99–1.04) 0.17
aVR 115 ± 18 101 ± 14 <0.0001 1.05 (1.02–1.09) 0.001 1.05 (1.02–1.10) 0.001
aVR > 100 ms; n (%) 20 (53%) 32 (80%) 0.01 3.6 (1.32–9.81) 0.01 3.75 (1.35–10.39) 0.01
aVL 95 ± 25 81 ± 19 0.02 1.02 (1.00–1.05) 0.02 1.03 (1.00–1.06) 0.02
aVF 110 ± 22 101 ± 16 0.03 1.02 (1.00–1.05) 0.04 1.02 (0.99–1.05) 0.06
V1 102 ± 19 92 ± 23 0.02 1.02 (1.00–1.04) 0.03 1.03 (1.00–1.05) 0.01
V2 98 ± 21 86 ± 21 0.01 1.03 (1.00–1.05) 0.02 1.03 (1.00–1.05) 0.02
V3 103 ± 18 98 ± 19 0.17 1.02 (0.99–1.04) 0.17
V4 110 ± 20 100 ± 21 0.03 1.02 (1.00–1.04) 0.03 1.02 (1.00–1.04) 0.04
V5 108 ± 23 102 ± 18 0.18 1.01 (0.99–1.03) 0.18
V6 110 ± 22 101 ± 15 0.03 1.02 (1.00–1.05) 0.04 1.03 (1.00–1.05) 0.02
Derived indices
Min P wave duration. (ms) 79 ± 15 72 ± 19 0.09 1.02 (0.99–1.04) 0.10
Max  P wave duration. (ms) 129 ± 18 117 ± 14 0.001 1.04 (1.01–1.08) 0.003 1.05 (1.01–1.08) 0.002
P wave variance (ms) 299 ± 233 230 ± 192 0.13 1.00 (0.99–1.00) 0.14
P wave dispersion (ms) 50 ± 20 45 ± 20 0.22 1.01 (0.99–1.03) 0.22
P wave terminal force (ms) 3.6 ± 4.3 3.2 ± 3.1 0.61 1.03 (0.91–1.15) 0.61